Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Jul;88(1):62–66. doi: 10.1172/JCI115305

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.

R Bataille 1, D Chappard 1, C Marcelli 1, P Dessauw 1, P Baldet 1, J Sany 1, C Alexandre 1
PMCID: PMC296003  PMID: 2056131

Abstract

Considering the special relation of human multiple myeloma (MM) to bones, it is of importance to clarify the early steps of bone involvement in this disease. In this work, using bone histomorphometry (including histoenzymologic and kinetic studies for the first time), we have evaluated the bone remodeling (i.e., bone resorption and bone formation rates) of 16 individuals with early MM in comparison with that of 10 with benign monoclonal gammopathy (BMG) and that of 17 patients with previously untreated overt MM. A significantly increased osteoblastic recruitment was observed in the individuals with early MM when compared with those with BMG (P less than 0.01). A significant (P less than 0.01) increased bone resorption (i.e., eroded surfaces, osteoclast numbers and surfaces) was observed from the early stage of MM in comparison with the BMG status where bone resorption remained within the normal range. At the tissue level, there was no difference in terms of bone resorption between early and overt MM. On the other hand, osteoblast activity was significantly reduced in patients with overt MM (P less than 0.05 by comparison with those with early MM). A significant enhancement of osteoblastic recruitment with an increased generation of new osteoclasts is an early critical event in the pathogenesis of human MM. Of particular importance is the early stimulation of osteoblasts, since these cells produce high amounts of IL-6, a potent myeloma cell growth factor and a critical cytokine for the formation of osteoclasts in the bone marrow.

Full text

PDF
66

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartl R., Frisch B., Fateh-Moghadam A., Kettner G., Jaeger K., Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol. 1987 Mar;87(3):342–355. doi: 10.1093/ajcp/87.3.342. [DOI] [PubMed] [Google Scholar]
  2. Barton B. E., Mayer R. IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. J Immunol. 1989 Nov 15;143(10):3211–3216. [PubMed] [Google Scholar]
  3. Bataille R., Chappard D., Alexandre C., Dessauw P., Sany J. Importance of quantitative histology of bone changes in monoclonal gammopathy. Br J Cancer. 1986 Jun;53(6):805–810. doi: 10.1038/bjc.1986.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bataille R., Chappard D., Marcelli C., Rossi J. F., Dessauw P., Baldet P., Sany J., Alexandre C. Osteoblast stimulation in multiple myeloma lacking lytic bone lesions. Br J Haematol. 1990 Dec;76(4):484–487. doi: 10.1111/j.1365-2141.1990.tb07904.x. [DOI] [PubMed] [Google Scholar]
  5. Bataille R., Delmas P., Sany J. Serum bone gla-protein in multiple myeloma. Cancer. 1987 Jan 15;59(2):329–334. doi: 10.1002/1097-0142(19870115)59:2<329::aid-cncr2820590227>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  6. Bataille R., Grenier J., Sany J. Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients. Blood. 1984 Feb;63(2):468–476. [PubMed] [Google Scholar]
  7. Beigbeder M., Chappard D., Alexandre C., Vico L., Palle S., Riffat G. Improved algorithms for automatic bone histomorphometry on a numerized image analysis system. J Microsc. 1988 May;150(Pt 2):151–160. doi: 10.1111/j.1365-2818.1988.tb04605.x. [DOI] [PubMed] [Google Scholar]
  8. Canalis E., McCarthy T., Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest. 1988 Feb;81(2):277–281. doi: 10.1172/JCI113318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chappard D., Alexandre C., Camps M., Montheard J. P., Riffat G. Embedding iliac bone biopsies at low temperature using glycol and methyl methacrylates. Stain Technol. 1983 Sep;58(5):299–308. doi: 10.3109/10520298309066802. [DOI] [PubMed] [Google Scholar]
  10. Chappard D., Alexandre C., Riffat G. Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem. 1983;27(2):75–85. [PubMed] [Google Scholar]
  11. Cozzolino F., Torcia M., Aldinucci D., Rubartelli A., Miliani A., Shaw A. R., Lansdorp P. M., Di Guglielmo R. Production of interleukin-1 by bone marrow myeloma cells. Blood. 1989 Jul;74(1):380–387. [PubMed] [Google Scholar]
  12. Delmas P. D., Charhon S., Chapuy M. C., Vignon E., Briancon D., Edouard C., Meunier P. J. Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma. Metab Bone Dis Relat Res. 1982;4(3):163–168. doi: 10.1016/0221-8747(82)90013-3. [DOI] [PubMed] [Google Scholar]
  13. Durie B. G., Salmon S. E., Mundy G. R. Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. Br J Haematol. 1981 Jan;47(1):21–30. doi: 10.1111/j.1365-2141.1981.tb02758.x. [DOI] [PubMed] [Google Scholar]
  14. Felix R., Elford P. R., Stoercklé C., Cecchini M., Wetterwald A., Trechsel U., Fleisch H., Stadler B. M. Production of hemopoietic growth factors by bone tissue and bone cells in culture. J Bone Miner Res. 1988 Feb;3(1):27–36. doi: 10.1002/jbmr.5650030106. [DOI] [PubMed] [Google Scholar]
  15. Feyen J. H., Elford P., Di Padova F. E., Trechsel U. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 1989 Aug;4(4):633–638. doi: 10.1002/jbmr.5650040422. [DOI] [PubMed] [Google Scholar]
  16. Gailani S., McLimans W. F., Mundy G. R., Nussbaum A., Roholt O., Zeigel R. Controlled environment culture of bone marrow explants from human myeloma. Cancer Res. 1976 Apr;36(4):1299–1304. [PubMed] [Google Scholar]
  17. Garrett I. R., Durie B. G., Nedwin G. E., Gillespie A., Bringman T., Sabatini M., Bertolini D. R., Mundy G. R. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med. 1987 Aug 27;317(9):526–532. doi: 10.1056/NEJM198708273170902. [DOI] [PubMed] [Google Scholar]
  18. Ishimi Y., Miyaura C., Jin C. H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990 Nov 15;145(10):3297–3303. [PubMed] [Google Scholar]
  19. Josse R. G., Murray T. M., Mundy G. R., Jez D., Heersche J. N. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor. J Clin Invest. 1981 May;67(5):1472–1481. doi: 10.1172/JCI110177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kawano M., Yamamoto I., Iwato K., Tanaka H., Asaoku H., Tanabe O., Ishikawa H., Nobuyoshi M., Ohmoto Y., Hirai Y. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood. 1989 May 1;73(6):1646–1649. [PubMed] [Google Scholar]
  21. Klein B., Zhang X. G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood. 1989 Feb;73(2):517–526. [PubMed] [Google Scholar]
  22. Kurihara N., Bertolini D., Suda T., Akiyama Y., Roodman G. D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol. 1990 Jun 1;144(11):4226–4230. [PubMed] [Google Scholar]
  23. Kurihara N., Suda T., Miura Y., Nakauchi H., Kodama H., Hiura K., Hakeda Y., Kumegawa M. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood. 1989 Sep;74(4):1295–1302. [PubMed] [Google Scholar]
  24. Kyle R. A., Lust J. A. Monoclonal gammopathies of undetermined significance. Semin Hematol. 1989 Jul;26(3):176–200. [PubMed] [Google Scholar]
  25. MacDonald B. R., Mundy G. R., Clark S., Wang E. A., Kuehl T. J., Stanley E. R., Roodman G. D. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res. 1986 Apr;1(2):227–233. doi: 10.1002/jbmr.5650010210. [DOI] [PubMed] [Google Scholar]
  26. Marcelli C., Chappard D., Rossi J. F., Jaubert J., Alexandre C., Dessauw P., Baldet P., Bataille R. Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma. Cancer. 1988 Sep 15;62(6):1163–1170. doi: 10.1002/1097-0142(19880915)62:6<1163::aid-cncr2820620620>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  27. Medeiros L. J., Picker L. J., Gelb A. B., Strickler J. G., Brain S. W., Weiss L. M., Horning S. J., Warnke R. A. Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas. J Clin Oncol. 1989 Aug;7(8):1009–1017. doi: 10.1200/JCO.1989.7.8.1009. [DOI] [PubMed] [Google Scholar]
  28. Merlini G., Parrinello G. A., Piccinini L., Crema F., Fiorentini M. L., Riccardi A., Pavesi F., Novazzi F., Silingardi V., Ascari E. Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol. 1990 Jan-Feb;8(1):23–30. doi: 10.1002/hon.2900080104. [DOI] [PubMed] [Google Scholar]
  29. Mundy G. R., Raisz L. G., Cooper R. A., Schechter G. P., Salmon S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974 Nov 14;291(20):1041–1046. doi: 10.1056/NEJM197411142912001. [DOI] [PubMed] [Google Scholar]
  30. Palle S., Chappard D., Vico L., Riffat G., Alexandre C. Evaluation of the osteoclastic population in iliac crest biopsies from 36 normal subjects: a histoenzymologic and histomorphometric study. J Bone Miner Res. 1989 Aug;4(4):501–506. doi: 10.1002/jbmr.5650040408. [DOI] [PubMed] [Google Scholar]
  31. Parfitt A. M., Drezner M. K., Glorieux F. H., Kanis J. A., Malluche H., Meunier P. J., Ott S. M., Recker R. R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987 Dec;2(6):595–610. doi: 10.1002/jbmr.5650020617. [DOI] [PubMed] [Google Scholar]
  32. Radl J., Croese J. W., Zurcher C., van den Enden-Vieveen M. H., Brondijk R. J., Kazil M., Haaijman J. J., Reitsma P. H., Bijvoet O. L. Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer. 1985 Mar 1;55(5):1030–1040. doi: 10.1002/1097-0142(19850301)55:5<1030::aid-cncr2820550518>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  33. Rossi J. F., Bataille R., Chappard D., Alexandre C., Janbon C. B cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Study of nine cases. Am J Med. 1987 Jul;83(1):10–16. doi: 10.1016/0002-9343(87)90491-8. [DOI] [PubMed] [Google Scholar]
  34. Rossi J. F., Bataille R. In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions. Br J Cancer. 1984 Jul;50(1):119–121. doi: 10.1038/bjc.1984.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stashenko P., Dewhirst F. E., Peros W. J., Kent R. L., Ago J. M. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol. 1987 Mar 1;138(5):1464–1468. [PubMed] [Google Scholar]
  36. Thomson B. M., Mundy G. R., Chambers T. J. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol. 1987 Feb 1;138(3):775–779. [PubMed] [Google Scholar]
  37. Thomson B. M., Saklatvala J., Chambers T. J. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med. 1986 Jul 1;164(1):104–112. doi: 10.1084/jem.164.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Valentin-Opran A., Charhon S. A., Meunier P. J., Edouard C. M., Arlot M. E. Quantitative histology of myeloma-induced bone changes. Br J Haematol. 1982 Dec;52(4):601–610. doi: 10.1111/j.1365-2141.1982.tb03936.x. [DOI] [PubMed] [Google Scholar]
  39. Zhang X. G., Bataille R., Jourdan M., Saeland S., Banchereau J., Mannoni P., Klein B. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood. 1990 Dec 15;76(12):2599–2605. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES